These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 39050010)

  • 21. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
    Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
    Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimating the Instantaneous Asymptomatic Proportion With a Simple Approach: Exemplified With the Publicly Available COVID-19 Surveillance Data in Hong Kong.
    Li C; Zhao S; Tang B; Zhu Y; Ran J; Li X; He D
    Front Public Health; 2021; 9():604455. PubMed ID: 34012950
    [No Abstract]   [Full Text] [Related]  

  • 23. New Surveillance Metrics for Alerting Community-Acquired Outbreaks of Emerging SARS-CoV-2 Variants Using Imported Case Data: Bayesian Markov Chain Monte Carlo Approach.
    Yen AM; Chen TH; Chang WJ; Lin TY; Jen GH; Hsu CY; Wang ST; Dang H; Chen SL
    JMIR Public Health Surveill; 2022 Nov; 8(11):e40866. PubMed ID: 36265134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Characteristics of SARS-CoV-2 Omicron infection in children imported from Hong Kong].
    Ma WJ; Wang XS; Tian H; Zhu YF; Wei ZQ; Xu J; Zhu QR; Zeng M
    Zhonghua Er Ke Za Zhi; 2022 Jun; 60(6):539-544. PubMed ID: 35658359
    [No Abstract]   [Full Text] [Related]  

  • 25. Epidemiological characteristics of 17 imported patients infected with SARS-CoV-2 Omicron variant.
    Liu X; Chen M; Zhou Z; Chen D; Mo J; Liu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):344-351. PubMed ID: 35545327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measures implemented in the school setting to contain the COVID-19 pandemic.
    Krishnaratne S; Littlecott H; Sell K; Burns J; Rabe JE; Stratil JM; Litwin T; Kreutz C; Coenen M; Geffert K; Boger AH; Movsisyan A; Kratzer S; Klinger C; Wabnitz K; Strahwald B; Verboom B; Rehfuess E; Biallas RL; Jung-Sievers C; Voss S; Pfadenhauer LM
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD015029. PubMed ID: 35037252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiological characteristics of the first 100 cases of coronavirus disease 2019 (COVID-19) in Hong Kong Special Administrative Region, China, a city with a stringent containment policy.
    Lai CKC; Ng RWY; Wong MCS; Chong KC; Yeoh YK; Chen Z; Chan PKS
    Int J Epidemiol; 2020 Aug; 49(4):1096-1105. PubMed ID: 32601677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrinsic and Effective Severity of Coronavirus Disease 2019 Cases Infected With the Ancestral Strain and Omicron BA.2 Variant in Hong Kong.
    Wong JY; Cheung JK; Lin Y; Bond HS; Lau EHY; Ip DKM; Cowling BJ; Wu P
    J Infect Dis; 2023 Nov; 228(9):1231-1239. PubMed ID: 37368235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Control of COVID-19 in Australia through quarantine: the role of special health accommodation (SHA) in New South Wales, Australia.
    Fotheringham P; Anderson T; Shaw M; Jewitt J; Storey H; Hutchings O; Cartwright J; Gupta L
    BMC Public Health; 2021 Jan; 21(1):225. PubMed ID: 33504347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-flight transmission of wild-type SARS-CoV-2 and the outbreak potential of imported clusters of COVID-19: a review of published evidence.
    Kelly D; Bambury N; Boland M
    Global Health; 2021 Aug; 17(1):93. PubMed ID: 34419084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of BNT162b2 and Sinovac vaccines against the transmission of SARS-CoV-2 during Omicron-predominance in Hong Kong: A retrospective cohort study of COVID-19 cases.
    Zhao S; Guo Z; Sun S; Hung CT; Leung EYM; Wei Y; Wang H; Li K; Yam CHK; Chow TY; Gao J; Jia KM; Chong KC; Yeoh EK
    J Clin Virol; 2023 Sep; 166():105547. PubMed ID: 37453162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolving Epidemiological Characteristics of COVID-19 in Hong Kong From January to August 2020: Retrospective Study.
    Kwok KO; Wei WI; Huang Y; Kam KM; Chan EYY; Riley S; Chan HHH; Hui DSC; Wong SYS; Yeoh EK
    J Med Internet Res; 2021 Apr; 23(4):e26645. PubMed ID: 33750740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series.
    Hung IF; Cheng VC; Li X; Tam AR; Hung DL; Chiu KH; Yip CC; Cai JP; Ho DT; Wong SC; Leung SS; Chu MY; Tang MO; Chen JH; Poon RW; Fung AY; Zhang RR; Yan EY; Chen LL; Choi CY; Leung KH; Chung TW; Lam SH; Lam TP; Chan JF; Chan KH; Wu TC; Ho PL; Chan JW; Lau CS; To KK; Yuen KY
    Lancet Infect Dis; 2020 Sep; 20(9):1051-1060. PubMed ID: 32539986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventing and Mitigating SARS-CoV-2 Transmission - Four Overnight Camps, Maine, June-August 2020.
    Blaisdell LL; Cohn W; Pavell JR; Rubin DS; Vergales JE
    MMWR Morb Mortal Wkly Rep; 2020 Sep; 69(35):1216-1220. PubMed ID: 32881850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reopening International Borders without Quarantine: Contact Tracing Integrated Policy against COVID-19.
    Yu Z; Zhu X; Liu X; Wei T; Yuan HY; Xu Y; Zhu R; He H; Wang H; Wong MS; Jia P; Guo S; Shi W; Chen W
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-Effectiveness of Public Health Measures to Control COVID-19 in China: A Microsimulation Modeling Study.
    Wang Q; Shi N; Huang J; Yang L; Cui T; Ai J; Ji H; Xu K; Ahmad T; Bao C; Jin H
    Front Public Health; 2021; 9():726690. PubMed ID: 35059369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of a Hotel-Based COVID-19 Isolation and Quarantine Strategy for Persons Experiencing Homelessness.
    Fuchs JD; Carter HC; Evans J; Graham-Squire D; Imbert E; Bloome J; Fann C; Skotnes T; Sears J; Pfeifer-Rosenblum R; Moughamian A; Eveland J; Reed A; Borne D; Lee M; Rosenthal M; Jain V; Bobba N; Kushel M; Kanzaria HK
    JAMA Netw Open; 2021 Mar; 4(3):e210490. PubMed ID: 33651111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reducing travel-related SARS-CoV-2 transmission with layered mitigation measures: symptom monitoring, quarantine, and testing.
    Johansson MA; Wolford H; Paul P; Diaz PS; Chen TH; Brown CM; Cetron MS; Alvarado-Ramy F
    BMC Med; 2021 Apr; 19(1):94. PubMed ID: 33849546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantifying the improvement in confirmation efficiency of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the early phase of the outbreak in Hong Kong in 2020.
    Ran J; Zhao S; Zhuang Z; Chong MKC; Cai Y; Cao P; Wang K; Lou Y; Wang W; Gao D; Yang L; He D; Wang MH
    Int J Infect Dis; 2020 Jul; 96():284-287. PubMed ID: 32413609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indirect contact with nature, lifestyle, and mental health outcomes during mandatory hotel quarantine in Hong Kong.
    Hazan H; Chan CS
    J Ment Health; 2023 Aug; 32(4):835-841. PubMed ID: 36382637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.